← All medicines

Breathing and allergy

Nerandomilast

Independent educational summary · Sources checked November 20, 2026

A targeted oral treatment for adults with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis under current labeling.

Profile scope: Nerandomilast. Confirm the exact product and route; formulations and combination products are not interchangeable.

Possible side effects

Diarrhea, nausea, appetite reduction, weight loss, fatigue, dizziness and depression are reported adverse effects.

Serious risks and warning signs

Persistent diarrhea or vomiting can compromise hydration and nutrition. Report substantial weight loss or new depression promptly. The linked label does not justify inventing a boxed warning or assuming that every patient develops serious injury.

A question for your healthcare team

How will weight, bowel symptoms and mood be followed, and do my other lung medicines change tolerability or interactions?

What to do with this information

Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.

Sources

Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.